Trial intelligence / Profile preview

Longxuetongluo Capsule in Recovery-Phase Cerebral Infarction

ChiCTR-OIC-16007950Phase 4Not yet recruiting

Sponsor
IEC of The First Affiliated Hospital of Tijianjin University of Traditional Chinese Medcine
Start
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of longxuetongluo in brain infarction, sponsored by IEC of The First Affiliated Hospital of Tijianjin University of Traditional Chinese Medcine. Planned start May 2015; status: not yet recruiting.

02

Drugs

longxuetongluo
03

Conditions

brain infarction

Beyond the preview

Go deeper on ChiCTR-OIC-16007950.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OIC-16007950.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call